Analysts expect IM Cannabis Corp. to report revenue of 16.15 M for Q4 25, against a range of 15.56 M to 16.75 M. The most recent reported quarter, Q3 25, came in at 9.89 M, a 32.9% miss against the 14.75 M consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 8.79 M | 10.81 M | 9.91 M | 9.24 M | 8.93 M | 9.22 M | 9.89 M | - | - | - | - | - | - | - | - | |
| High Estimate | 7.88 M | 9.56 M | 11.59 M | 9.94 M | 11.75 M | 14.73 M | 15.95 M | 16.75 M | 14.00 M | 15.47 M | 14.59 M | 25.02 M | 19.63 M | 15.84 M | 15.48 M | |
| Low Estimate | 7.18 M | 8.84 M | 10.48 M | 9.00 M | 10.59 M | 12.67 M | 13.54 M | 15.56 M | 12.95 M | 13.03 M | 13.52 M | 20.57 M | 16.39 M | 14.69 M | 13.24 M | |
| Consensus Estimate | 7.53 M | 9.20 M | 11.03 M | 9.47 M | 11.17 M | 13.70 M | 14.75 M | 16.15 M | 13.47 M | 14.25 M | 14.05 M | 22.79 M | 18.01 M | 15.26 M | 14.36 M |
Analysts expect IM Cannabis Corp. to report earnings per share of 2.45 for Q4 25, against a range of 2.28 to 2.62. The most recent reported quarter, Q3 25, came in at -16.06 , in line with the -0.65 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -55.10 | -5.04 | -8.78 | -6.67 | 1.93 | -1.96 | -16.06 | - | - | - | - | - | - | - | - | |
| High Estimate | -23.92 | -22.65 | -19.58 | -10.85 | -7.17 | -3.63 | -0.60 | 2.62 | 8.61 | 6.07 | -18.26 | -4.97 | 43.19 | 34.67 | -6.27 | |
| Low Estimate | -26.54 | -25.49 | -23.64 | -13.11 | -8.69 | -4.27 | -0.70 | 2.28 | 7.61 | 5.45 | -19.86 | -5.43 | 39.81 | 29.97 | -7.05 | |
| Consensus Estimate | -25.23 | -24.07 | -21.61 | -11.98 | -7.93 | -3.95 | -0.65 | 2.45 | 8.11 | 5.76 | -19.06 | -5.20 | 41.50 | 32.32 | -6.66 |